Gemtuzumab ozogamicin (Mylotarg) in children with refractory or relapsed acute myeloid leukemia.

D Reinhardt; S Diekamp; G Fleischhack; C Corbacioglu; H Jurgens; M Dworzak; G.J.L. Kaspers; U. Creutzig; C.M. Zwaan

doi:10.1159/000075606

Gemtuzumab ozogamicin (Mylotarg) in children with refractory or relapsed acute myeloid leukemia.

D Reinhardt, S Diekamp, G Fleischhack, C Corbacioglu, H Jurgens, M Dworzak, G.J.L. Kaspers, U. Creutzig, C.M. Zwaan

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	269-72
Journal	Onkologie
Volume	27
Issue number	3
DOIs	https://doi.org/10.1159/000075606
Publication status	Published - 2004

Access to Document

10.1159/000075606

Embargoed Document

170545
Final published version, 71.7 KB

Cite this

@article{be56d89576194b4e99d36399195b0adb,

title = "Gemtuzumab ozogamicin (Mylotarg) in children with refractory or relapsed acute myeloid leukemia.",

author = "D Reinhardt and S Diekamp and G Fleischhack and C Corbacioglu and H Jurgens and M Dworzak and G.J.L. Kaspers and U. Creutzig and C.M. Zwaan",

year = "2004",

doi = "10.1159/000075606",

language = "English",

volume = "27",

pages = "269--72",

journal = "Onkologie",

issn = "0378-584X",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - Gemtuzumab ozogamicin (Mylotarg) in children with refractory or relapsed acute myeloid leukemia.

AU - Reinhardt, D

AU - Diekamp, S

AU - Fleischhack, G

AU - Corbacioglu, C

AU - Jurgens, H

AU - Dworzak, M

AU - Kaspers, G.J.L.

AU - Creutzig, U.

AU - Zwaan, C.M.

PY - 2004

Y1 - 2004

U2 - 10.1159/000075606

DO - 10.1159/000075606

M3 - Article

SN - 0378-584X

VL - 27

SP - 269

EP - 272

JO - Onkologie

JF - Onkologie

IS - 3

ER -